1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
(
- Contribution to journal › Article
- 2023
-
Mark
Elevated low-density lipoprotein cholesterol : An inverse marker of morbidity and mortality in patients with myocardial infarction
(
- Contribution to journal › Article
-
Mark
Inhaled ciclesonide in adults hospitalised with COVID-19 : a randomised controlled open-label trial (HALT COVID-19)
(
- Contribution to journal › Article
- 2021
-
Mark
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes : A Swedish nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19 : population-based cohort study in Sweden (SCAPIS)
(
- Contribution to journal › Article
- 2020
-
Mark
Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction : A simulation study
(
- Contribution to journal › Article
-
Mark
Temporal trends in bleeding events in acutemyocardial infarction : Insights from the SWEDEHEARTregistry
(
- Contribution to journal › Article
- 2018
-
Mark
External Validation of the DAPT Score in a Nationwide Population
(
- Contribution to journal › Article
- 2016
-
Mark
Worldwide trends in diabetes since 1980 : A pooled analysis of 751 population-based studies with 4.4 million participants
(
- Contribution to journal › Article
- 2015
-
Mark
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331288 participants
(
- Contribution to journal › Article